These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 6443689)
1. Development and administration of live Shigella vaccines. Pencu E Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):231-50. PubMed ID: 6443689 [No Abstract] [Full Text] [Related]
2. Antidysentery immunoprophylaxis in the light of current data about the pathogenicity of Shigella and the antidysentery immunity. Meitert T Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):195-230. PubMed ID: 6443688 [No Abstract] [Full Text] [Related]
3. Vaccine strain Sh. flexneri T32-Istrati. Studies in animals and in volunteers. Antidysentery immunoprophylaxis and immunotherapy by live vaccine Vadizen (Sh. flexneri T32-Istrati). Meitert T; Pencu E; Ciudin L; Tonciu M Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):251-78. PubMed ID: 6400299 [No Abstract] [Full Text] [Related]
7. [Safety, reactivity and effectiveness testing of live shigella flexneri vaccines in laboratory animals and children (author's transl)]. Sergeev VV; Elkina SI; Solodnikov YP; Shuster BY; Sergeeva GS; Bulk VF; Bobkin SV Acta Microbiol Acad Sci Hung; 1974; 21(1-2):121-8. PubMed ID: 4216247 [No Abstract] [Full Text] [Related]
8. Live dysentery vaccine "Vadizen" (T32-Istrati) immunogenicity against Shigella-like challenge in animals. Ciudin L; Meitert T; Pencu E; Gheorghe G; Tonciu M; Mihai I; Manase R Arch Roum Pathol Exp Microbiol; 1986; 45(3-4):247-56. PubMed ID: 3300598 [No Abstract] [Full Text] [Related]
9. [Humoral and cellular immunity in patients with acute dysentery]. Burkin AV; Kasimova NB; Galimzianova RM; Gor'kova AI; Shishkina SN Ter Arkh; 1991; 63(11):22-5. PubMed ID: 1810054 [No Abstract] [Full Text] [Related]
10. Molecular genetics of virulence in Shigella. Binns MM Microbiol Sci; 1985 Sep; 2(9):275-8. PubMed ID: 2484669 [TBL] [Abstract][Full Text] [Related]
11. Pathogenesis, genetics of virulence, and immunity in Shigellosis. Formal SB; Kapfer C; Hale TL Kansenshogaku Zasshi; 1988 Mar; 62 Suppl():329-42. PubMed ID: 3138359 [No Abstract] [Full Text] [Related]
12. [Experimental model of keratoconjunctival infections in the study of immunity against Shigella]. Cefalù M; Puglisi C G Mal Infett Parassit; 1972 Apr; 24(4):281-9. PubMed ID: 5050309 [No Abstract] [Full Text] [Related]
14. Attenuated Salmonella typhi and Shigella as live oral vaccines and as live vectors. Levine MM; Galen J; Barry E; Noriega F; Tacket C; Sztein M; Chatfield S; Dougan G; Losonsky G; Kotloff K Behring Inst Mitt; 1997 Feb; (98):120-3. PubMed ID: 9382732 [No Abstract] [Full Text] [Related]
15. Strategies for development of potential candidate Shigella vaccines. Lindberg AA; Pál T Vaccine; 1993; 11(2):168-79. PubMed ID: 8438615 [TBL] [Abstract][Full Text] [Related]
16. Immunogenic value of live, inactivated and cell-free dysentery vaccines. Meitert T; Sulea IT; Gogulescu L; Baron E; Tempea C; Istrati G Acta Microbiol Acad Sci Hung; 1974; 21(1-2):103-7. PubMed ID: 4613127 [No Abstract] [Full Text] [Related]
17. [The pathogenicity factors of Shigella studied as the bases for the design of diagnostic and prophylactic preparations]. Bondarenko VM Zh Mikrobiol Epidemiol Immunobiol; 1996; (3):29-34. PubMed ID: 8771725 [TBL] [Abstract][Full Text] [Related]
18. [A morphologic study of the harmlessness of live dysentery vaccines from streptomycin dependent mutants of Sh. flexneri]. Levenbuk IS; Sergeev VV; Elkina SI; Kavtaradze KN; Dzhikidze EK Zh Mikrobiol Epidemiol Immunobiol; 1972 Feb; 49(2):18-22. PubMed ID: 4623775 [No Abstract] [Full Text] [Related]
19. Current aspects of Shigella pathogenesis. Torres AG Rev Latinoam Microbiol; 2004; 46(3-4):89-97. PubMed ID: 17061529 [TBL] [Abstract][Full Text] [Related]
20. [A study of the streptomycin-dependent mutants of shigella]. Sergeev VV; Taratorina OM; Elkina SI Zh Mikrobiol Epidemiol Immunobiol; 1967 Sep; 44(9):28-32. PubMed ID: 4892079 [No Abstract] [Full Text] [Related] [Next] [New Search]